| Estrogens determine the efficacy of cancer immunotherapy in obese males with melanoma | JCI insight |  | | 2025 | 1 | 0 |
|
| Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review | Non-coding RNA | | | 2024 | 173 | 78 |
|
| GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model | Frontiers in immunology | | | 2024 | 197 | 72 |
|
| Dual targeting of H2S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by miR-939-5p effectively curbs triple negative breast cancer | Heliyon | | | 2023 | 194 | 72 |
|
| Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer Cells | Antioxidants | | | 2023 | 317 | 141 |
|
| Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer | Oncoimmunology | | | 2023 | 244 | 120 |
|
| PEGylated Gold Nanoparticles Target Age-Associated B Cells In Vivo | ACS nano | | | 2022 | 365 | 63 |
|
| Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles | Journal of controlled release | | | 2022 | 394 | 416 |
|
| HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasis | European Journal of Immunology | | | 2021 | 259 | 192 |
|
| The interleukin-1 cytokine family members: role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy | Cytokine & growth factor reviews | | | 2021 | 273 | 192 |
|
| Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice | ACS Nano | | | 2021 | 399 | 553 |
|
| Silver-Containing Titanium Dioxide Nanocapsules for Combating Multidrug-Resistant Bacteria | International Journal of Nanomedicine | | | 2020 | 486 | 181 |
|
| Médiateurs de l'aspirine dans l'arsenal anticancéreux ? | Revue médicale suisse | | | 2020 | 324 | 438 |
|
| Polymer-coated gold nanospheres do not impair the innate immune function of human B lymphocytes in vitro | ACS Nano | | | 2019 | 453 | 576 |
|
| Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study | European Journal of Pharmaceutics and Biopharmaceutics | | | 2019 | 589 | 742 |
|
| Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation | Biomaterials | | | 2019 | 542 | 711 |
|
| CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes | Journal of Experimental Medicine | | | 2019 | 493 | 385 |
|
| Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists | Pharmacological Research | | | 2019 | 551 | 1,174 |
|
| Bionanomaterials for the Delivery of Cancer Immunotherapy | Chimia | | | 2019 | 433 | 329 |
|
| Hook length of the bacterial flagellum is optimized for maximal stability of the flagellar bundle | PLOS Biology | | | 2018 | 486 | 386 |
|
| Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation | International Journal of Pharmaceutics | | | 2018 | 646 | 927 |
|
| Engineered hybrid spider silk particles as delivery system for peptide vaccines | Biomaterials | | | 2018 | 576 | 462 |
|
| Antimicrobial silver-filled silica nanorattles with low immunotoxicity in dendritic cells | Nanomedicine | | | 2017 | 549 | 563 |
|
| Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade | Oncoimmunology | | | 2017 | 250 | 235 |
|
| NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon response | Oncotarget | | | 2017 | 518 | 241 |
|
| A rapid screening method to evaluate the impact of nanoparticles on macrophages | Nanoscale | | | 2017 | 508 | 419 |
|
| Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses | Oncoimmunology | | | 2016 | 247 | 174 |
|
| TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function | Oncoimmunology | | | 2016 | 238 | 209 |
|
| P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model | Journal for immunotherapy of cancer | | | 2014 | 29 | 41 |
|
| Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells | Retrovirology | | | 2012 | 33 | 47 |
|
